A new IARC live webinar on evidence in primary cancer prevention By Ogkologos - November 11, 2021 535 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR Implanted “Drug Factories” Deliver Cancer Treatment Directly to Tumors April 7, 2022 The EPA’s Limitations On This Toxic Pesticide Put Children At Risk... February 5, 2021 Research with integrity – why colour blindness is a research integrity... February 28, 2023 Political Interests Are A Major Adversary in the War on Women July 6, 2021 Load more HOT NEWS New Research on Treating Hormone Receptor-Positive Breast Cancer From SABCS 2020 COVID-19: “The really hard part is we know what needs to... FDA Approves Neoadjuvant/Adjuvant Durvalumab for Patients with Resectable NSCLC EMA Recommends Extension of Indications for Pirtobrutinib
